Aim: Apolipoprotein E (ApoE) plays an important role in the transport and metabolism of lipids. Recent studies show that bone mass is increased in young apoE -/-mice. In this study we investigated the bone phenotype and metabolism in aged apoE -/-mice. Methods: Femurs and tibias were collected from 18-and 72-week-old apoE -/-mice and their age-matched wild-type (WT) littermates, and examined using micro-CT and histological analysis. Serum levels of total cholesterol, oxidized low-density lipoprotein (ox-LDL) and bone turnover markers were measured. Cultured bone mesenchymal stem cells (BMSCs) from tibias and femurs of 18-week-old apoE -/-mice were used in experiments in vitro. The expression levels of Sirt1 and Runx2 in bone tissue and BMSCs were measured using RT-PCR and Western blot analysis. Results: Compared with age-matched WT littermates, young apoE -/-mice exhibited high bone mass with increased bone formation, accompanied by higher serum levels of bone turnover markers OCN and TRAP5b, and higher expression levels of Sirt1, Runx2, ALP and OCN in bone tissue. In contrast, aged apoE -/-mice showed reduced bone formation and lower bone mass relative to age-matched WT mice, accompanied by lower serum OCN levels, and markedly reduced expression levels of Sirt1, Runx2, ALP and OCN in bone tissue. After BMSCs were exposed to ox-LDL (20 µg/mL), the expression of Sirt1 and Runx2 proteins was significantly increased at 12 h, and then decreased at 72 h. Treatment with the Sirt1 inhibitor EX527 (10 µmol/L) suppressed the expression of Runx2, ALP and OCN in BMSCs. Conclusion: In contrast to young apoE -/-mice, aged apoE -/-mice showe lower bone mass than age-matched WT mice. Long-lasting exposure to ox-LDL decreases the expression of Sirt1 and Runx2 in BMSCs, which may explain the decreased bone formation in aged apoE -/-mice.
Introduction
Apolipoprotein E (apoE) is a structural component of lipoproteins and is required for the plasma clearance of lipoproteins through binding with lipoprotein receptors. ApoE-deficient (apoE -/-) mice exhibit severe hyperlipidemia and develop spontaneous atherosclerosis [1, 2] . Dyslipidemia and atherosclerosis can often co-exist with osteoporosis, and lipid-lowering agents have been shown to have positive effects on osteoporosis [3] [4] [5] [6] [7] . However, only a few studies have described the skeletal changes caused by ApoE deficiency. Some studies have reported that young and adult apoE -/-mice exhibit a high bone mass phenotype due to increased bone formation rates [8] [9] [10] . Indeed, these mice show increased bone mass compared to that in wild-type (WT) controls despite the potentially adverse effects of spontaneous hypercholesterolemia and atherosclerosis. An in vitro study has further found that ApoE is expressed in primary murine calvaria osteoblasts at late stages of differentiation [8] . Conversely, when fed a high-fat diet, ApoEdeficient mice show reduced bone formation by stimulating p53-mediated apoptosis of osteoblastic cells [11] . Another study has found that at 28 weeks of age, the total bone mineral den-sity (tBMD) of apoE -/-mice was significantly higher than that of WT mice, whereas at 40 weeks of age, there was no significant difference in tBMD between apoE -/-and WT mice [12] . These studies suggest that the skeletal phenotype of apoE -/-mice may be influenced by a variety of factors, including age, high-fat diet, and renal function. Therefore, it is necessary to study the bone phenotype and metabolism of aged apoE -/-mice. ApoE gene isoforms are related to aging, longevity, and a number of age-related diseases, including atherogenesis and osteoporosis [13] [14] [15] [16] [17] [18] [19] . ApoE-deficient mice develop many premature degenerative changes linked to different ages [20] , suggesting that ApoE-deficient mice may serve as a good model to study aging. Another important gene that is correlated with lifespan and age-related diseases belongs to the sirtuin family [21, 22] . Sirtuins are highly conserved NAD + -dependent deacetylases that have been shown to regulate lifespan in lower organisms and to affect diseases related to aging in mammals [23, 24] . Studies have found that Sirt1 plays an important role in the pathogenesis of atherosclerosis [25, 26] . Sirt1 also plays a key role in osteoblast regulation [27] and mesenchymal stem cell differentiation [28] . One study has shown that endothelial cell-specific Sirt1 transgenic ApoE-knockout mice have fewer atherosclerotic lesions than apoE -/-controls. This finding suggests that the observed effects of ApoE knockout on aging might be related to the insufficient expression of Sirt1 [29] . A recent study has reported that aged (2.2-year-old) mesenchymal stem cell (MSC)-specific Sirt1 knockout (MSCKO) mice show reduced cortical bone thickness and trabecular volume. Young mice, however, exhibit less-pronounced effects [30] . To date, no studies have described the levels of Sirt1 expression in the bone tissues of apoE -/-mice. Therefore, in this study, we determined the skeletal phenotypes of aged apoE -/-mice using micro-computed tomography (micro-CT). To further analyze the possible mechanisms related to this phenotype, we evaluated Sirt1 expression in the bone tissues of apoE -/-mice and examined the role of Sirt1 in osteoblast differentiation from bone marrow-derived mesenchymal stem cells (BMSCs).
Materials and methods

Experimental animals
All animal studies were conducted with the approval of the Committee on Animal Resources at Huadong Hospital, Fudan University. Male apoE -/-mice on a C57Bl/6J background and their WT littermates were purchased from the Nanjing Biomedical Research Institute (Nanjing University, Nanjing, China) at 18 weeks of age. The mice were maintained in groups under a strict 12-h light/dark cycle in a temperaturecontrolled environment (25 °C) with free access to food and water. All animals were fed a standard mouse diet containing 20.50% protein, 4.68% fat, 1.23% calcium, and 0.91% phosphorus.
Micro-CT analysis
Femurs collected from apoE -/-mice and WT mice at 18 and 72 weeks of age were dissected, cleaned, fixed in 10% Millonig's formalin, and transferred to 100% ethanol. The femurs were then analyzed using a SkyScan-1176 micro-CT instrument (Bruker Corporation, Kontich, Belgium). Scans were performed using PANalytical's Microfocus Tube, with a 8.96-µmol/L voxel size, a 45 kV, 500 µA, and a 0.6° rotation step (180° angular range). For trabecular bone, micro-CT evaluation was performed on a 1-mm region of metaphyseal spongiosa in the distal femur. The regions were located 0.5 mm above the growth plate. The index included tissue bone mineral density (BMD) and directly measured bone volume fraction (BV/TV), thickness (Tb.Th), number (Tb.N), and separation (Tb.Sp). For cortical bone, measurements were performed on a 0.5-mm region of the mid-diaphysis of the femur. The index included total area (Tt.Ar), cortical area (Tt.Cr), thickness (Ct.Th), and porosity. NR Econ software Version 1.6 (Bruker Corporation) was used for the three-dimensional (3D) reconstruction and viewing of images.
Histological analysis
The tibias of each mouse were fixed for 1 d in 4% paraformaldehyde in phosphate-buffered saline (PBS) at 4 °C. Specimens were decalcified in 10% EDTA in 0.05 mol/L Tris buffer for 7 d at 4 °C until the bones were soft and flexible. The samples were then processed and embedded in paraffin. Sections were cut and stained with hematoxylin and eosin (H&E) and histochemically analyzed for alkaline phosphatase (ALP) activity using a BCIP/NBT Kit (Beyotime Biotechnology, Nanjing, China) and analyzed for tartrate-resistant acid phosphatase (TRAP) activity using a Leukocyte Acid Phosphatase Kit for TRAP staining (Sigma, St Louis, MO, USA). Sections were then counterstained with methyl green and mounted in Kaiser's glycerol jelly. Calculations were performed on a minimum of duplicate specimens from five mice in each group.
Serum bone turnover markers and biochemistry Serum from each mouse was analyzed individually and in duplicate for the bone formation marker osteocalcin (OCN) using enzyme-linked immunosorbent assays (ELISAs) with a Mouse Osteocalcin EIA Kit (Immutopics International, San Clemente, CA, USA), and for the bone resorption marker tartrate-resistant acid phosphatase 5b (TRAP5b) using Mouse TRAP Assays (Immunodiagnostic Systems Inc, Boldon, UK) according to the manufacturer's instructions. The average values of duplicate measurements were obtained for each mouse. Serum total cholesterol (TC) was measured using a Hitachi 917 autoanalyzer (Tokyo, Japan), and serum oxidized low-density lipoprotein (ox-LDL) was measured using a mouse ox-LDL ELISA Kit (Uscn Life Science Inc, Wuhan, China).
Cell preparation and culture BMSCs were obtained from apoE -/-mice and WT mice (male, 18 weeks old). The femurs and tibias were removed under aseptic conditions. After removal of the surrounding muscle and connective tissue, the ends of the bones were cut to expose the bone marrow cavity. The cavity was washed three times with PBS, and the bone marrow was injected with L-DMEM medium. The collected cells were directly inoculated in 5 cells/well in a six-well culture plate and cultured in L-DMEM containing 10% fetal bovine serum (FBS). Some cells were cultured in experimental culture medium supplemented with 10 µmol/L EX-527 (Sigma) for 12 h and collected. Alternatively, cells were supplemented with 20 µg/mL ox-LDL (Peking Union-Biololgy Co Ltd, Beijing, China); ox-LDL was added every 24 h, and cells were collected at 12, 24, 48, or 72 h after ox-LDL was added.
Real-time reverse transcription polymerase chain reaction (RTqPCR)
The total RNA was extracted from tissues and cultured cells using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. Total RNA was reverse transcribed to cDNA using a QuantiTect Rev Transcription Kit (Qiagen, Chatsworth, CA, USA). The number of cDNA molecules in the reverse-transcribed samples was determined by real-time PCR using a modified method with a QuantiTect SYBR Green PCR Kit (Qiagen) on an Mx3000P Real-Time PCR system (Stratagene, La Jolla, CA, USA) according to the manufacturer's instructions. The primers were obtained from SBSgene (www.sbsgene.com) with the following sequences: Sirt1, 5′-GCAGGTTGCAGGAATCCAA-3′ and 5′-GGCAA-GATGCTGTTGCAAA-3′ (63 bp, XM_006514342.1); Runtrelated transcription factor 2 (Runx2), 5′-TGTTCTCTGATC-GCCTCAGTG-3′ and 5′-CCTGGGATCTGTAATCTGACTCT-3′ (146 bp, XM_006523545.1); ALP, 5′-CACGCGATGCAA-CACTCAGG-3′ and 5′-GCATGTCCCCGGGCTCAAAGA-3′ (479 bp, XM_ 006538500.1); osteocalcin (OCN), 5′-ACCCTG-GCTGCGCTCTGTCTCT-3′ and 5′-GATGCGTTTGTAGGC-GGTCTTCA-3′ (240 bp, NM_007541.3); and glyceraldehyde -3-phosphate dehydrogenase (GAPDH), 5′-AGCCTCGTCCC-GTAGACA-3′ and 5′-CTCGCTCCTGGAAGATGG-3′ (255 bp, NM_008084.3). The conditions for PCR were 12.5 µL of SYBR Green I Master Mix, 0.25 µmol/L each of forward and reverse primer, and 2 µL of sample, and H 2 O to a final volume of 25 µL. A melting curve was obtained at the end of each run to discriminate specific from nonspecific cDNA products. The cDNA content was normalized by subtracting the cycle number of the GAPDH gene expression from that of the target gene expression (∆Ct=Ct of target gene-Ct of GAPDH), and the gene expression level was calculated using the 2
method.
Western blot analysis
All samples were lysed using cell lysis buffer (Beyotime, Nanjing, China) plus a 1:100 volume of phenylmethanesulfonyl fluoride (100 mmol/L). Protein was then quantified using BCA protein assays (P0012; Beyotime) with bovine serum albumin (BSA) as a standard. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) sample loading buffer (P0015, Beyotime) was added to the protein samples, and samples were heated for 5 min in a boiling water bath. Aliquots of samples (40 µg) were then subjected to SDS-PAGE using 12% gels under reducing conditions and electroblotted onto polyvinylidene difluoride (PVDF) membranes (Ipvh00010; Millipore, Bedford, MA, USA). The membranes were blocked with 5% fat-free dry milk in TBST (0.1% Tween-20 and 0.1 mol/L NaCl in 0.1 mol/L Tris-HCl, pH 7.5) for 2 h at room temperature and then incubated overnight at 4 °C with the following primary antibodies: rabbit anti-Sirt1 (1:2000; Proteintech, Chicago, IL, USA); goat anti-Runx2 (1:1000; Santa Cruz Biotechnology, Santa Cruz, CA, USA); and mouse anti-GAPDH (1:10 000; Kangcheng, Shanghai, China). The membranes were then incubated with horseradish peroxidase-conjugated secondary antibodies (1:5000; Santa Cruz Biotechnology) at room temperature for 1 h, and proteins were detected by chemiluminescence (P0018; Beyotime). Each incubation step was followed by three washes (10 min each) with TBST. The protein bands were quantitatively analyzed using an image analysis system (QuantityOne software; Bio-Rad, Hercules, CA, USA).
Statistical analysis
The data are presented as the mean±standard deviation (SD). Statistical significance was determined using Student's t-tests or one-way analysis of variance (ANOVA) followed by Dunnett's test. Analyses were performed using SPSS 17.0 (Chicago, IL, USA), and differences with P-values less than 0.05 were considered significant.
Results
Detection of decreased bone volume in aged apoE -/-mice by micro-CT First, we performed quantitative analyses of the bone phenotype using reconstruction of a micro-CT on the distal metaphyseal region of the femurs from male WT mice and apoE -/-mice that were 18 and 72 weeks of age ( Figure 1 ). Relative to WT mice, femurs from 18-week-old apoE -/-mice exhibited a marked increase in trabecular BMD, BV/TV, and Tb.Th (+30.43%, +39.69%, and +30.68%, respectively; P<0.05; Figure  1A and 1C). No changes in cortical parameters were observed between the femurs of young WT and apoE -/-mice ( Figure 1E  and 1G ). In contrast, in 72-week-old animals, the extent of total bone loss was much greater in apoE -/-mice. The trabecular BMD decreased significantly in apoE -/-mice compared with that in WT mice (-30.68%, P<0.01). This result was also accompanied by decreases in body weight (P<0.05), femur trabecular BV/TV (-48.19%, P<0.01), Tb.Th (-30.58%, P<0.05), and Tb.N (-60.02%, P<0.01; Figure 1B and 1D) . Moreover, measurements of cortical bone from aged apoE -/-mice showed decreased cortical thickness (Ct.Th; -40.96%, P<0.05) and increased cortical porosity (+32.14%, P<0.05; Figure 1F and 1H).
Reduced bone formation in aged apoE
-/-mice To determine whether the differences in bone architecture were accompanied by corresponding changes in markers of bone formation and resorption, we performed histomorphometric analysis of tibias from 18-and 72-week-old WT (Figure 2) . In 18-week-old mice, the results showed that the ratio of the ALP-positive osteoblast surface relative to the total bone surface (OB.S/BS) was increased (+28.70%, P<0.05) in apoE -/-mice compared with that in WT mice ( Figure 2C ). Somewhat contradictory to the results in the young apoE -/-mice, the ALP-positive area (OB.S/BS) decreased significantly in 72-week-old apoE -/-mice compared with that in WT mice (-40.7%, P<0.05; Figure 2D ). No changes were observed in the osteoclast surface/bone surface (OC.S/BS) between the aged apoE -/-mice and WT mice at both young and old ages ( Figure  2E and 2F). Consistently with results from previous studies, serum levels of OCN, a marker of bone formation, increased 1.22-fold in apoE -/-mice compared with that in WT mice at 18 weeks of age (P<0.05, Figure 3C ). Serum levels of Trap5b also increased significantly (P<0.05, Figure 3D ), whereas in 72-week-old animals, the serum levels of OCN were decreased relative to those of WT mice (-31.57%, P<0.05; Figure 3C ). However, the serum levels of Trap5b did not change significantly in aged apoE -/-mice relative to that in WT mice ( Figure  3D ). The serum levels of TC and ox-LDL were significantly higher in both 18-week-and 72-week-old apoE -/-mice compared with those in age-matched WT mice (P<0.01, Figure 3A and 3B).
Sirt1 expression decreased in bone tissues from aged apoE -/-mice
To further analyze the mechanisms mediating the rapid decrease in bone mass and bone formation in aged apoE -/-mice, we measured Sirt1 and Runx2 expression in bone tissue in both young and aged apoE -/-mice. In 18-week-old mice, Sirt1 mRNA levels were 2.12-fold higher in apoE -/-mice than in WT mice (P<0.05). Similarly, the mRNA levels of the bone formation markers Runx2, ALP, and OCN were significantly higher in apoE -/-mice after normalization (2.9-, 1.29-, and 1.73-fold, respectively; P<0.05; Figure 4A ). Western blot analysis confirmed these results ( Figure 4C ). However, in 72-week-old apoE -/-mice, protein and mRNA levels of Sirt1 and Runx2 in femurs were significantly decreased compared with those in age-matched WT animals (P<0.01, Figure 4B and 4D).
Ox-LDL induced a time-dependent decrease in Sirt1 expression during the osteogenic differentiation of BMSCs from apoE -/-mice in vitro
To further investigate whether Sirt1 plays an active role in the differentiation of BMSCs, we treated BMSCs from 18-week-old apoE -/-mice with the Sirt1 inhibitor EX527. After treatment with EX527 (10 µmol/L), the mRNA ( Figure 5A ) and protein levels ( Figure 5B ) of Runx2 decreased significantly (-23.57%, P<0.05 and -54.38%, P<0.01, respectively).
Ox-LDL was much higher in aged apoE
-/-mice than in WT mice ( Figure 3B) ; therefore, we examined whether Sirt1 was involved in the osteogenic differentiation of BMSCs during long-term exposure of apoE -/-mice to ox-LDL ( Figure 6A  and 6B) . RT-PCR analysis showed that ox-LDL (20 μg/mL) enhanced the expression of Sirt1 mRNA in BMSCs in the first 12 h (3.3-fold; P<0.05). However, after prolonged treatment with ox-LDL, the expression of Sirt1 mRNA decreased at 72 h compared with that at 0 h (-48%; P<0.05), which indicated that the long-term effects of ox-LDL accumulation downregulated Sirt1 expression in the BMSCs of apoE -/-mice. Similar results were observed for Runx2 mRNA and protein levels.
Discussion
In this study, we investigated the changes in bone phenotype and metabolism of aged apoE -/-mice to elucidate the mechanisms involved. Our results showed that aged apoE -/-mice had lower bone mass compared with age-matched WT mice. Moreover, continuous stimulation with ox-LDL decreased Sirt1 and Runx2 expression in BMSCs, providing insight into the mechanisms of reduced bone formation in aged apoE -/-mice.
We found that femur trabecular bone mass and BV/TV were higher in young apoE -/-mice than in WT mice. This was consistent with the results of most previous studies in which the mice were usually 3-8 months old [8] [9] [10] . However, in our study, the trabecular volume of aged apoE -/-mice decreased significantly compared with that of WT mice of the same age. Histological changes in the tibias further confirmed the decreased bone formation in aged apoE -/-mice. In addition, our in vivo study showed that Runx2 expression in bone tissue was decreased in aged apoE -/-mice compared with that in WT [31, 32] . Interestingly, in our study, we found that serum OCN in aged apoE -/-mice decreased significantly, whereas the levels of the bone resorption marker Trap5b were not different between apoE -/-and WT mice. These results indicated that there were significant age-induced reductions in bone mass and the bone formation rate in aged apoE -/-mice. To the best of our knowledge, our present study is the first to report the bone phenotype and metabolism of aged apoE -/-mice. A similar study by Wang et al has found that although the trabecular BMD (tBMD) of femurs from 28-week-old apoE -/-mice was higher than that of WT mice, there was no significant difference in the tBMD between 40-week-old apoE -/-mice and WT mice. Moreover, the Tb.N and Tb.Th in trabecular bone increased with age and reached a peak at 28 weeks of age, after which these parameters decreased [12] . Previous studies have found that ApoE is expressed in bone morphogenetic protein-2 (BMP-2)-treated mesenchymal progenitors and in mineralized primary osteoblast cultures [33] . ApoE can enhance the uptake of vitamin K-containing chylomicron remnants by human osteoblasts [34] . Moreover, although ApoE knockout itself directly affects osteogenic lineage cells and promotes bone formation in vitro [9, 33, 34] , the final bone phenotype is the result of the combined effects of multiple factors. At a young age, the effects of ApoE deficiency on bones may play a more dominant positive role compared with the negative effects of hyperlipidemia and spontaneous atherosclerosis. However, in animals consuming a high-fat diet, ApoE deficiency has been shown to reduce bone formation through stimulation of p53-mediated apoptosis [11] . During aging, apoE -/-mice exhibited an accumulation of ox-LDL, accelerated atherosclerosis, increased production of reactive oxygen species, and enhanced cell aging; these features may lead to aggravated bone loss. Hypercholesterolemia-induced oxidant stress could accelerate the aging of hematopoietic stem cells from apoE -/-mice [35] . Compared with young mice, aged apoE -/-mice exhibit higher production of reactive oxygen species, leading to DNA damage and apoptosis of bone marrow cells [36] . Therefore, it is not surprising that the aged apoE -/-mice in this study exhibited decreased bone volume in contrast to the high bone mass observed in young mice. Similar contradictory situations were also found in other organs in apoE BMSCs from 18-week-old apoE -/-mice were treated with ox-LDL (20 μg/mL [37] . Furthermore, various bone phenotypes during different stages of aging in the same type of mouse have also been demonstrated in other gene-knockout animal models. For example, in young (2-month-old) MSCKO mice, the effects of Sirt1 loss on bone are less pronounced, affecting only trabecular thickness without changing overall bone volume. However, in aged (2.2-year-old) MSCKO mice, cortical bone thickness and trabecular BV/TV are reduced 25% and 23%, respectively, as a result of reduced numbers of osteoblasts and lower bone formation rates [30] . Lyer et al [38] have reported that the bone formation rate is 40% higher in Foxo1,-3-4 f/f and Osx1-Cre mice than in WT mice at 7 weeks of age. However, at 24 months of age, there are no differences in bone formation rates between the two types of mice.
To further analyze the mechanisms mediating this rapid decrease in bone mass and bone formation in aged apoE -/-mice, we first measured Sirt1 expression in bone tissues in young and aged apoE -/-mice. Sirt1 is the founding member of a group of proteins that have been well studied in aging research [39, 40] , and Sirt1 affects a variety of biological functions, including DNA repair, energy metabolism, tumor suppression, and mitochondrial homeostasis [41, 42] . In addition, transgenic mice with approximately 2-fold higher levels of global Sirt1 expression are protected against metabolic decline due to aging [43] . These mice are also protected against aging-induced bone loss [44] . Sirt1 +/− heterozygous female mice exhibit reduced bone mass characterized by decreased bone formation and increased marrow apoptosis [45] . The functional association between apoE knockout and Sirt1 has rarely been studied, and existing studies have focused mainly on atherosclerosis. Sirt1 has been shown to be atheroprotective in apoE -/-mice [25, 46, 47] , whereas genetic overexpression of Sirt1 in LDL receptor-deficient (Ldlr -/-) mice enhances atherosclerosis [44] . Stein et al have reported that young hypercholesterolemic apoE -/-Sirt1 +/-mice treated with lipopolysaccharide exhibit more pronounced endothelial expression of intercellular cell adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) compared with apoE -/-Sirt1 +/+ mice, suggesting that endogenous Sirt1 reduces endothelial activation in apoE -/-mice [25] . However, the association between apoE knockout and Sirt1 expression in the bone has not been studied before. Unlike the results observed in the arteries, in this study, we found that the expression of Sirt1 mRNA and protein in the bones of young apoE -/-mice was higher than that in the bones of WT mice (see additional data in Figure 7) , whereas in aged apoE -/-mice, the expression of Sirt1 decreased significantly compared with that of WT mice. As mentioned above, Sirt1 plays an important positive role in bone metabolism, and the decreased expression of Sirt1 was consistent with the decreased bone mass and reduced bone formation rate in aged apoE -/-mice. Based on these findings, we hypothesize that Sirt1 may be involved in the age-induced bone loss observed in apoE -/-mice. To test this hypothesis in more detail, we measured the expression of Sirt1 and Runx2 in BMSCs after stimulation with ox-LDL in vitro. Ox-LDL generates reactive oxygen species (ROS), which accelerate the aging of BMSCs [48] . In our study, after an initial increase (in the first 12 h), Sirt1 protein and mRNA expression in BMSCs from apoE -/-mice decreased more rapidly and became even lower than that at 0 h. These data indicated that continuous incubation with ox-LDL downregulated Sirt1 expression in the BMSCs of the apoE -/-mice. A recent study examining the effects of Sirt1 on the efferocytosis of ox-LDL-induced apoptotic RAW264.7 cells (macrophages) has revealed that the expression levels of Sirt1 and autophagy marker proteins are increased at 24 h and then decreased at 48 h [49] . Moreover, inhibition of Sirt1 in EX527-treated BMSCs reduces the expression of Runx2, suggesting that Sirt1 is involved in bone osteogenic differentiation in mice. The Sirt1 agonist resveratrol regulates Sirt1/Runx2 expression, thereby promoting the osteogenic differentiation of BMSCs [50] . Resveratrol promotes the osteogenesis of human mesenchymal stem cells by upregulating Runx2 gene expression via the Sirt1/ Foxo3a axis [51] . This may explain why aged apoE -/-mice exhibited reduced bone formation rates and bone mass.
Together, our data showed that aged apoE -/-mice exhibited low bone mass and low bone formation. Sirt1 may play an important role in age-induced bone loss in aged apoE -/-mice. However, the direct relationship between ApoE knockout and Sirt1 expression in bone is still unclear. Further studies are required to elucidate these mechanisms.
Conclusions
Aged apoE -/-mice had lower bone mass compared with age-matched WT mice. Long-term treatment with ox-LDL decreased the expression of Sirt1 in BMSCs; this mechanism contributed to the low bone formation observed in these mice. 
